Nicotine as a Potential Neuroprotective Agent for Parkinson's Disease

Movement Disorders - United States
doi 10.1002/mds.25028
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Wiley

Related search

Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2012English

Hypoxia-Inducible Factors as Neuroprotective Agent in Alzheimer's Disease

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2017English

Herbal Medicines as Neuroprotective Agent: A Mechanistic Approach

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2017English

Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease

Frontiers in Pharmacology
Pharmacology
2019English

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2018English

Detection of Alpha-Synuclein Conformational Variants From Gastro-Intestinal Biopsy Tissue as a Potential Biomarker for Parkinson's Disease

Neuropathology and Applied Neurobiology
Forensic MedicinePathologyNeurologyHistologyPhysiology
2018English

miR‑133b Is a Potential Diagnostic Biomarker for Alzheimer's Disease and Has a Neuroprotective Role

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Memantine Prodrug as a New Agent for Alzheimer’s Disease

Scientific Reports
Multidisciplinary
2019English

Differential Neuroprotective Effects of 14-3-3 Proteins in Models of Parkinson's Disease

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy